Innovative Research in Cancer Nanotechnology (IRCN) (R01)

This grant encourages applications promoting transformative discoveries in cancer biology and/or oncology through the use of nanotechnology. Proposed projects should address major barriers in cancer biology and/or oncology using nanotechnology and should focus on mechanistic studies to expand the fundamental understanding of nanomaterial and/or nano-device interactions with biological systems.

Funding: $450,000 per year
Duration: 5 years 

Research Authority due date: 10 days prior to submission

LOI (Encouraged) due dates:4.10.20, 6.4.21, 4.10.21, 5.4.22, 3.10.22, 4.4.23
Full proposal due dates: 4.11.20, 6.5.21, 4.11.21, 5.5.22, 3.11.22, 4.5.23